Your browser doesn't support javascript.
loading
CAMTA1-related disorder: Phenotypic and molecular characterization of 26 new individuals and literature review.
Al-Kateb, Hussam; Au, P Y Billie; Berland, Siren; Cogne, Benjamin; Demurger, Florence; Fluss, Joel; Isidor, Bertrand; Frank, L Matthew; Varvagiannis, Konstantinos; Koolen, David A; McDonald, Marie; Montgomery, Sarah; Moortgat, Stéphanie; Deprez, Marie; Karadurmus, Deniz; Paulsen, Julie; Reis, André; Rieger, Melissa; Vasileiou, Georgia; Willing, Marcia; Shinawi, Marwan.
Afiliação
  • Al-Kateb H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Au PYB; University of Calgary, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.
  • Berland S; Department of medical genetics, Haukeland University Hospital, Bergen, Norway.
  • Cogne B; Centre Hospitalier Universitaire de Nantes, Service de G'en'etique M'edicale, Nantes, France.
  • Demurger F; Service de Génétique, Vannes, France.
  • Fluss J; Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
  • Isidor B; Centre Hospitalier Universitaire de Nantes, Service de G'en'etique M'edicale, Nantes, France.
  • Frank LM; Division of Neurology, Children's Hospital of The King's Daughters, Norfolk, Virginia, USA.
  • Varvagiannis K; Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
  • Koolen DA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • McDonald M; Duke University Medical Center, Durham, North Carolina, USA.
  • Montgomery S; Duke University Medical Center, Durham, North Carolina, USA.
  • Moortgat S; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium.
  • Deprez M; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium.
  • Karadurmus D; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium.
  • Paulsen J; Department of medical genetics, Haukeland University Hospital, Bergen, Norway.
  • Reis A; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Rieger M; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Vasileiou G; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Willing M; Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Shinawi M; Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri, USA.
Clin Genet ; 105(3): 294-301, 2024 03.
Article em En | MEDLINE | ID: mdl-38044714
ABSTRACT
Calmodulin-binding transcriptional activator 1 (CAMTA1) is highly expressed in the brain and plays a role in cell cycle regulation, cell differentiation, regulation of long-term memory, and initial development, maturation, and survival of cerebellar neurons. The existence of human neurological phenotypes, including cerebellar dysfunction with variable cognitive and behavioral abnormalities (CECBA), associated with CAMTA1 variants, has further supported its role in brain functions. In this study, we phenotypically and molecularly characterize the largest cohort of individuals (n = 26) with 23 novel CAMTA1 variants (frameshift-7, nonsense-6, splicing-1, initiation codon-1, missense-5, and intragenic deletions-3) and compare the findings with all previously reported cases (total = 53). We show that the most notable phenotypic findings are developmental delay/intellectual disability, unsteady or uncoordinated gait, hypotonia, behavioral problems, and eye abnormalities. In addition, there is a high incidence of dysarthria, dysgraphia, microcephaly, gastrointestinal abnormalities, sleep difficulties, and nonspecific brain MRI findings; a few of which have been under-reported. More than one third of the variants in this cohort were inherited from an asymptomatic or mildly affected parent suggesting reduced penetrance and variable expressivity. Our cohort provides a comprehensive characterization of the spectrum of phenotypes and genotypes among individuals with CECBA and the large data will facilitate counseling and formulating management plans and surveillance recommendations for these individuals.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Deficiência Intelectual Limite: Humans Idioma: En Revista: Clin Genet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Deficiência Intelectual Limite: Humans Idioma: En Revista: Clin Genet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos